Hyperkalemia
42 results
1 - 42- Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia
- Hyperkalaemia
- ACE + ARB does not improve outcomes in pts with T2DM with impaired renal function (VA NEPHRON)
- Trimethoprim or trimethoprim-sulfamethoxazole and risk of hyperkalaemia among patients taking renin-angiotensin system blockers
- Sodium polystyrene sulfonate linked to higher risk of hospitalization for adverse GI events
- ACE inhibitor + ARB = no benefit and increased risk
- Eplerenone reduces mortality in NYHA II heart failure
- Aliskiren not beneficial for chronic heart failure (ATMOSPHERE)
- Aldosterone receptor antagonists spironolactone and eplerenone for congestive heart failure
- Emergency interventions for hyperkalaemia
- Antibiotic therapy does not prevent death or acute exacerbations in adults with idiopathic pulmonary fibrosis
- The combination of ACEIs plus ARBs is overused and dangerous
- Spironolactone for hypertension: Cochrane systematic review
- Aliskiren worsens outcomes in high-risk diabetics
- No reduction in mortality or readmission with addition of aliskiren for HF patients (ASTRONAUT)
- Early initiation of RRT does not improve mortality in patients with sepsis and severe acute kidney injury
- Early initiation of RRT in critically ill patients with AKI does not lower 90-day mortality
- No improved patient-oriented outcomes with sacubitril/valsartan in adults with heart failure and preserved EF (PARALLAX)
- Hi-dose ARB slightly better than standard dose in pts with CHF (HEAAL)
- Timing of RRT in critically ill patients with acute kidney injury: verdict still out
- No mortality difference between early and delayed initiation of renal replacement therapy in critically ill patients with AKI
- Blood pressure control for diabetic retinopathy
- Guideline for the management of primary adrenal insufficiency
- Salt substitute reduces mortality and stroke in elderly patients who have a history of, or are at risk of, stroke
- Low‐sodium salt substitutes and blood pressure
- Finerenone decreases hospitalization for heart failure in patients with type 2 diabetes and chronic kidney disease (NNT = 189/year)
- Diabetic kidney disease (diabetic nephropathy)
- BP target of 120 no better than 140 in T2DM (ACCORD)
- Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking renin-angiotensin system blockers
- Spironolactone for hypertension